Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

IMMUNEX CORP Create: Alert

All | News | Filings
Date FiledTypeDescription
11/17/2011 CT ORDER Form CT ORDER - Confidential treatment order
09/02/2009 CT ORDER Form CT ORDER - Confidential treatment order
05/16/2002 8-K Quarterly results
05/09/2002 10-Q Quarterly Report for the period ended March 31, 2002
05/07/2002 8-K Other events, Financial statements and exhibits
Docs: "Telephone Number, Including Area Code)",
"SUPPLY AGREEMENT DATED APRIL 12, 2002",
"SINCE THE PRODUCT WAS FIRST INTRODUCED, SERIOUS INFECTIONS, SOME INVOLVING DEATH, HAVE BEEN REPORTED IN PATIENTS USING ENBREL. MANY OF THESE INFECTIONS OCCURRED IN PATIENTS WHO WERE PRONE TO INFECTIONS, SUCH AS THOSE WITH ADVANCED OR POORLY CONTROLLED DIABETES. RARE CASES OF TUBERCULOSIS HAVE ALSO BEEN REPORTED. ENBREL SHOULD BE DISCONTINUED IN PATIENTS WITH SERIOUS INFECTIONS. DO NOT START ENBREL IF YOU HAVE AN INFECTION OF ANY TYPE OR IF YOU HAVE AN ALLERGY TO ENBREL OR ITS COMPONENTS. ENBREL SHOULD BE USED WITH CAUTION IN PATIENTS PRONE TO INFECTION. CONTACT YOUR PHYSICIAN IF YOU HAVE ANY QUESTIONS ABOUT ENBREL OR INFECTIONS."
05/03/2002 425 Form 425 - Prospectuses and communications, business combinations
05/03/2002 8-K Other events, Financial statements and exhibits
04/30/2002 8-K Other events, Financial statements and exhibits
Docs: "Changed Since Last Report)",
"Opinion of Merrill Lynch, Pierce, Fenner & Smith Incorporated",
"Immunex Announces Settlement Of Certain Litigations Relating To Merger With Amgen Inc."
04/29/2002 425 Form 425 - Prospectuses and communications, business combinations
04/29/2002 8-K Other events, Financial statements and exhibits
Docs: "SECURITIES AND EXCHANGE COMMISSION",
"Immunex Announces First Quarter 2002 Results"
04/10/2002 425 Form 425 - Prospectuses and communications, business combinations
04/10/2002 425 Form 425 - Prospectuses and communications, business combinations
04/05/2002 425 Form 425 - Prospectuses and communications, business combinations
03/14/2002 425 Form 425 - Prospectuses and communications, business combinations
03/14/2002 425 Form 425 - Prospectuses and communications, business combinations
03/13/2002 425 Form 425 - Prospectuses and communications, business combinations
03/08/2002 10-K Annual Report for the period ended December 31, 2001
03/08/2002 8-K/A Acquisition or disposition of assets, Financial statements and exhibits
Docs: "UNAUDITED PRO FORMA CONDENSED COMBINING FINANCIAL STATEMENTS"
02/12/2002 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/07/2002 425 Form 425 - Prospectuses and communications, business combinations
02/07/2002 425 Form 425 - Prospectuses and communications, business combinations
02/01/2002 425 Form 425 - Prospectuses and communications, business combinations
01/31/2002 425 Form 425 - Prospectuses and communications, business combinations
01/23/2002 425 Form 425 - Prospectuses and communications, business combinations
01/22/2002 425 Form 425 - Prospectuses and communications, business combinations
01/18/2002 8-K Acquisition or disposition of assets, Financial statements and exhibits
Docs: "SECURITIES AND EXCHANGE COMMISSION",
"Amendment No. 1 to Purchase Agreement, by and among American Home Products Corporation, AHP Subsidiary Holding Corporation and Immunex Corporation",
"Secured Promissory Note, by Immunex Corporation in favor of American Home Products Corporation and AHP Subsidiary Holding Corporation",
"Pledge Agreement, by and among American Home Products Corporation, AHP Subsidiary Holding Corporation and Immunex Corporation",
"Limited Waiver and Amendment Letter Agreement, among Immunex Corporation, American Home Products Corporation and AHP Subsidiary Holding Corporation"
01/14/2002 425 Form 425 - Prospectuses and communications, business combinations
01/11/2002 425 Form 425 - Prospectuses and communications, business combinations
12/27/2001 425 Form 425 - Prospectuses and communications, business combinations
12/21/2001 SC 13D AMGEN INC reports a 41% stake in IMMUNEX CORPORATION
12/18/2001 SC 13D/A WYETH reports a 41% stake in Immunex Corporation
12/17/2001 8-K Other events, Financial statements and exhibits
Docs: "Agreement and Plan of Merger, dated as of December 16, 2001, by and among Amgen Inc., AMS Acquisition Inc. and Immunex Corporation",
"Shareholder Voting Agreement, dated as of December 16, 2001, by and among Amgen Inc., American Home Products Corporation, MDP Holdings, Inc. and Lederle Parenterals, Inc",
"04:47 EST DECEMBER 17, 2001"
12/17/2001 425 Form 425 - Prospectuses and communications, business combinations
12/17/2001 425 Form 425 - Prospectuses and communications, business combinations
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy